BCI Pharma designs and synthesizes kinase inhibitor libraries. They identify novel, potent, and selective kinase inhibitor hits. They develop cell-based assays. They also plan to deliver medications for inflammatory diseases, CNS disorders, and cancer. Their goal is to create a world-renowned firm that its patients, customers, investors, business